SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-19-000145
Filing Date
2019-08-16
Accepted
2019-08-16 17:18:30
Documents
16
Period of Report
2019-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k63019earningsre.htm   iXBRL 8-K 34047
2 EXHIBIT 99.1 exh991-financials63019q220.htm EX-99.1 177527
8 moleculin-logo_horiza03.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000145.txt   706060

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbrx-20190814.xsd EX-101.SCH 4452
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbrx-20190814_cal.xml EX-101.CAL 634
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbrx-20190814_def.xml EX-101.DEF 1484
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbrx-20190814_lab.xml EX-101.LAB 28381
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbrx-20190814_pre.xml EX-101.PRE 14655
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k63019earningsre_htm.xml XML 4574
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 191034209
SIC: 2834 Pharmaceutical Preparations